PurposeState Health Agencies (SHAs) have developed public health genomics
(PHG) programs that play an instrumental role in advancing precision public
health, but there is limited research on their approaches. This study
examines how PHG programs attempt to mitigate or forestall health
disparities and inequities in the utilization of genomic medicine.MethodsWe compared PHG programs in three states: Connecticut, Michigan, and
Utah. We analyzed 85 in-depth interviews with SHA internal and external
collaborators and program documents. We employed a qualitative coding
process to capture themes relating to health disparities and inequities.ResultsEach SHA implemented population-level approaches to identify
individuals who carry genetic variants that increase risk of hereditary
cancers. However, each SHA developed a unique strategy—which we
label public health action repertoires—to reach specific subgroups
who faced barriers in accessing genetic services. These strategies varied
across states given demographics of the state population, state-level
partnerships, and availability of healthcare services.ConclusionOur findings illustrate the imperative of tailoring PHG programs to
local demographic characteristics and existing community resources.
Furthermore, our study highlights how integrating genomics into precision
public health will require multilevel, multisector collaboration to optimize
efficacy and equity.